Presentations

Filter by Category

All Blogs Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

February 20, 2018

2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”

Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure

December 8, 2017

Characterizing Disease Progression for Parkinson’s Disease to implement efficient trial designs

December 8, 2017

Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers

November 15, 2017

Using Data to Reimagine Clinical Trials

April 11, 2017

Allowing Respondents to Skip Items During Electronic Collection of Patient-Reported Outcome (PRO) Data: Does It Matter?

April 11, 2017

Evaluating the Conceptual Equivalence Between Paper and Three Electronic Data Collection Modes of the EQ-5D-5L Health Status Instrument

FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMRI) as a prognostic biomarker for pre-dementia clinical trials for Alzheimer disease therapeutics

Conrado, D.J., et al.; “FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMR

Informed consent ensuring access to anonymized patient-level data and biospecimen is critical to accelerating innovative Alzheimer disease treatments

Arnerić, S.P., et al.; “Informed consent ensuring access to anonymized patient-level data and biospecimen is critical to accele

Data sharing and standardization to expand a patient-level database of a regulatory-endorsed clinical trial simulator for Alzheimer disease (AD)

Burton, J., et al.; “Data sharing and standardization to expand a patient-level database of a regulatory-endorsed clinical trial

Previous89 10...13 Next